Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 2,405 | 2,528 | 2,137 | 2,458 | 2,218 |
| Operating Income | -2,405 | -2,528 | -2,137 | -2,458 | -2,218 |
| Other Income | 94 | 178 | 163 | 131 | 168 |
| Pre-tax Income | -2,311 | -2,350 | -1,974 | -2,327 | -2,050 |
| Net Income Continuous | -2,311 | -2,350 | -1,974 | -2,327 | -2,050 |
| Net Income | $-2,311 | $-2,350 | $-1,974 | $-2,327 | $-2,050 |
| EPS Basic Total Ops | 0.68 | -16.29 | -13.68 | -38.73 | -51.40 |
| EPS Basic Continuous Ops | 0.68 | -16.29 | -13.68 | -38.73 | -51.40 |
| EPS Diluted Total Ops | 0.68 | -16.29 | -13.68 | -38.73 | -51.40 |
| EPS Diluted Continuous Ops | 0.68 | -16.29 | -13.68 | -38.73 | -51.40 |
| EPS Diluted Before Non-Recurring Items | -12.24 | -16.43 | -13.64 | -38.81 | N/A |
| EBITDA(a) | $-2,380 | $-2,503 | $-2,112 | $-2,433 | $-2,192 |